chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, the first symptom that she had was starting to feel so hot, sweaty and would turn red, and would start sweating a lot.  The next day when it happened again she was sleeping and thinks it happened during her sleep that she started having a seizure.  Her body was twisting, her hands, her arms, her mouth and fell off the bed and hurt herself and woke up when she fell off the bed and hit her head.  She didn't know what happened and asked her daughter who is 6 and she told her that her body was shaking and that she had a lot of saliva coming out of her mouth.  She read that it was symptoms of a seizure.  Then it started happening repeatedly and she has it almost 2-3 times a month that she cannot control.  She is scared that it is going to happen to her while she is driving and her mind blacks out.  It just comes without warning and happens.  This all started since she got the vaccine.  She has gone to the doctor for this and they told her that it was syncope.  They didn't tell her what caused it.  They did not give her any medications for it.   With the testing they did not find any reason for that.    She went to the ER when she passed out outside, was sitting down and stood up and happened and hit her whole face on the concrete floor, and she had injuries due to that on 1/14/22.    She has had 9 events since receiving the vaccine in June, which she feels is not normal.  No family history of any seizures.
Fever started 9/29/17, Pt also with cough, vomiting, headache and sore throat.  9/30/17 presented to local ED with seizures and was transported to hospital, she remains there presently. Dx with FIRES syndrome.
ACCORDING TO HIS WIFE: PATIENT STARTED FEELING SICK IN THE EVENING 3 HOURS AFTER HE RECEIVED THE 2ND IMZ OF SHINGRIX (5/14/2019). HE HAD FLU LIKE SYMPTOMS THE NEXT DAY (5/15/2019). HE HAD FEVER, CHILL, HEADACHE, NAUSEA, DIFFICULTY BREATHING. HE SAW HIS PCP. HE WAS TESTED FOR FLU. NEGATIVE RESULT. DR. GAVE HIM RX FOR ZOFRAN AND ALBUTEROL INHALER.
A month after 2nd dose I began experiencing neck and shoulder stiffness that lasted for months, initially with negative ESR and CRP but eventually with increased inflammation and tendonitis (RS3PE) diagnosed as PMR on Dec 7, 2021.
No adverse event; dose was given to adults mistakenly; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly).    No concomitant information was reported. 051B22A was kept in the freezer upon receipt of shipment on 1 Aug 2022 and individual vials were put in the refrigerator on the day of use. dose was given to adults mistakenly and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. No treatment information was reported.
pt recv vax 15AUG96 & 17AUG96 t exp ocular ptosis of the rt eye w/exotropia, head tilted on one side;presented to MD;21AUG96 lab eval nl including T3 uptake, TSH, T4, free serum T4 & acetylcholine receptor modula AB;23AUG96 MRI;
Tested positive for COVID-19 by a rapid test; PCR test results are pending. Symptoms include chills, sore throat, mild cough, loose stool, blocked nose, no smell or taste at times.
I had a sore arm for about a day after receiving the vaccine. I tested positive for COVID-19 on 05/27/2023. I had bad headaches and fever. I had a telehealth visit with an urgent care provider and got a prescription for Paxlovid. I tolerated the medication without any complications. I have noticed that I get tired a little more than I use to after having COVID-19. The taste of salt seems to be stronger after having COVID-19.
Large red patch on arm at injection site. About 3x6 in size. Flat not raised. Warm to touch.  Mild itch. Resolved after 3 days.
received Pfizer covid 19 booster dose (third dose) on 10/19/21.  She had fever 12 hours later.  Three days later she developed vision loss in the left eye. MRI shows acute CVA left basal ganglion
Approximately 24 days after my second dose, I woke up feeling excruciating pain in my upper back, left arm and hands. It was both throbbing consistently and/or piercing, stabbing pain at intervals. I took a nap and some ibuprofen PM so I can sleep and ignore the pain. Went to ER the following day as pain didn't subside and was increasing in pain. X-ray showed nothing was wrong. Was prescribed two pain meds. Cold and hot compress were not alleviating the pain. Lasted for a whole week. Then pain was intermittent and less painful but still continuously throbbing. None at the upper back but pain focused on left arm/hand. Advised by ER doctor to go to primary doctor if pain does not subside in two days and did so. No new diagnosis from ER: perhaps inched nerve. It is strange what is happening to me. Felt better after another week. Relief from some huge pain until pain returned a week ago, starting Friday, May 14th. It's been throbbing since and pain is intermittent. I am again drinking ibuprofen and naproxen as prescribed before to ease the pain and allow me to sleep and work.
Pt received Tdap, IPV, Hepatitis B, Varicella, MMR, HPV QV 7/28/16. Within minutes pt started coughing, broken out in hives and c/o his throat and tongue swelling. Pt given 5 mg of Epi at 1:01 pm IM and 50 mg BENADRYL IM. O2 face mask. Hives none, throat and tongue decreased swelling.
Patient reports no known time or cause of any shoulder injury prior to or after Flu Vaccine.  Right Shoulder pain within hours after injection, increasing daily pain for several months until increased pain with loss of motion.  Treatment for pain required by PCP. Ortho referral made and completed.  SIRVA explained and suspected.
very ill; diarrhea; dry heat; weak; icky; couldn't get up of the bathroom; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very ill), DIARRHOEA (diarrhea), FEELING HOT (dry heat), ASTHENIA (weak) and FEELING ABNORMAL (icky) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced ILLNESS (very ill), DIARRHOEA (diarrhea), FEELING HOT (dry heat), ASTHENIA (weak), FEELING ABNORMAL (icky), HYPOKINESIA (couldn't get up of the bathroom) and VOMITING (vomiting). The patient was treated with PROMETHAZINE for Nausea, at an unspecified dose and frequency. At the time of the report, ILLNESS (very ill), DIARRHOEA (diarrhea), FEELING HOT (dry heat), ASTHENIA (weak), FEELING ABNORMAL (icky), HYPOKINESIA (couldn't get up of the bathroom) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included unspecified diabetes medications.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow -up received and contains No New Information.
Received Pfizer COVID vaccine on 2/6/21 and 1/15/21.   On 4/17/2021 developed loss of taste/smell.   Positive COVID test.
100.5°F fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (100.5°F fever) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (100.5°F fever). At the time of the report, PYREXIA (100.5°F fever) had resolved.            No Concomitant Medication was provided by the reporter. No treatment  was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30 Apr 2021: Updated event outcome
Booster; possible myocarditis; extreme fatigue; Cough; sore throat; something is going on with his heart; This is a spontaneous report from a non-contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number was not provided), dose 3 via an unspecified route of administration at the age of 71-year-old on an unspecified date (Batch/Lot number was not reported) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), all for Covid-19 immunization. The patient experienced possible myocarditis, extreme fatigue, cough, sore throat, something was going on with his heart on an unspecified date. Caller stated that he wanted to know about the symptoms of myocarditis. Stated that he had reported it to the doctor that he had extreme fatigue, cough, sore throat and it never went anywhere. Stated that he was trying to figure out how to request for cardiologist if something was going on with his heart. Is for the Covid 19 vaccination. Stated that he had the third dose. Stated that he was71 years old. Stated that he tried to notify the site on Pfizer but it would not take the report due to required information not filled in. Stated that he should go to his (name-withheld) doctor. The event possible myocarditis was serious for being medical significant. The outcome of events of event was unknown.     No follow up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.
Ongoing facial pain on right side of face starting Sept. 8. followed by migraine headache since 9/17.
About 3 days after initial side effects / dose (I. E. Nausea, muscle aches, swollen lymph nodes, chills for about 48 hours or less), I got a red itchy welt-like rash around the injection site and it's still there. First injection was in my right arm without side effects.
Pt had received a flu vaccine on 10/05/07 and was administered a flu vaccine on 12/19/07; pt was in clinic for TST.
Itchy, pink/red welts on bilateral lower extremities (below knee to ankle) that appeared approximately 24 hours after 3rd dose. Transitioned to itchy, red, macular papular rash, that has yet to resolve over one week later
1 hr p/vax given, pt had periorbital edema followed by hives; no resp distress; given Epi, Solumedrol, DPH;
Strong Headache; nausea; tiredness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04May2021 13:30 (Lot number: EW0173) at the age of 52 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, lot number: EW0158, Location: Left arm), administration date: 12Apr2021, when the patient was 52 years old, for Covid-19 immunization, reaction(s): "Sore arm for one day after 1st vaccination". The following information was reported: HEADACHE (non-serious) with onset 05May2021 03:30, outcome "not recovered", described as "Strong Headache"; NAUSEA (non-serious) with onset 05May2021 03:30, outcome "not recovered", described as "nausea"; FATIGUE (non-serious) with onset 05May2021 03:30, outcome "not recovered", described as "tiredness". Therapeutic measures were not taken as a result of headache, nausea, fatigue.  Additional information: It was reported that the facility type vaccine was Public Health Clinic/Administration facility. The adverse event: strong Headache, nausea, tiredness on day after 2nd vaccination. Headaches on several days after 2nd vaccination He did not receive any other medications within two weeks of the COVID vaccine. The patient did not tested Covid post vaccination. Patient did not had known allergies. He did not have any other medical history. Patient did not had Covid prior vaccination.  No follow-up attempts are possible. No further information is expected.
had a very strong pain in their chest, near their heart; like a fear or anxiety sensation that comes to their chest; Nausea; This spontaneous case was reported by a physician and describes the occurrence of CHEST PAIN (had a very strong pain in their chest, near their heart), CHEST DISCOMFORT (like a fear or anxiety sensation that comes to their chest) and NAUSEA (Nausea) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 20-Jan-2021. Concomitant products included FENOFIBRATE and ATORVASTATIN for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced CHEST PAIN (had a very strong pain in their chest, near their heart), CHEST DISCOMFORT (like a fear or anxiety sensation that comes to their chest) and NAUSEA (Nausea). On 25-Feb-2021, CHEST PAIN (had a very strong pain in their chest, near their heart) and NAUSEA (Nausea) had resolved. At the time of the report, CHEST DISCOMFORT (like a fear or anxiety sensation that comes to their chest) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Blood pressure measurement: 150 mmHg High and 127 mmHg Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 20-Jan-2021, the patient was tested positive for COVID. On 31-Jan-2021 the patient's quarantine was over and on 08-Feb-2021 the patient was feeling better.  On 25-Feb-2021, the patient was taken to the hospital to rule out that he had a heart attack. The patient's studies were normal. After the vaccination the patient had been left with a sensation, like a fear or anxiety sensation that comes to his chest. When the patient was doing activities he forgot and it was gone, but suddenly when he was in calm on their house that sensation came back.  Treatment medication include Ondansetron. The patient was given something else in the ambulance, it was a spray, they don't know what it was but they suppose it was something to control their blood pressure since it was in 127 when they got to the hospital.
blisters on lift hand:  sunday rash on both hands and apparent 100 small blisters on the back of each hand; monday doth hands and forearms torned solid red; either monday evening or tuesday evening my whole body itched and continued to do so for the next day and half.  Except  for the itching i felt fine
Information has been received from a licensed visiting nurse, via a company representative, concerning a female student in twelfth grade, who on 14-MAY-2007 was vaccinated at a high school health fair, with the first dose, 0.5ml of Gardasil.  Concomitant therapy included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA).  The nurse reported that after receiving the vaccination, the patient fainted, and later recovered on the same day, 14-MAY-2007.  The patient sought unspecified medical attention.  No further information is expected.
severe anaphylaxis reaction; This spontaneous case was reported by a physician and describes the occurrence of ANAPHYLACTIC REACTION (severe anaphylaxis reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANAPHYLACTIC REACTION (severe anaphylaxis reaction) (seriousness criterion medically significant). At the time of the report, ANAPHYLACTIC REACTION (severe anaphylaxis reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not reported.
Narrative: Patient presented to the ED on 2/13/2022 with a chief complaint of fever and shortness of breath. He tested positive for COVID-19 on 2/9/2022. In triage, SpO2 was 82% on room air. Labs in ED revealed normal CBC, renal insufficiency (Scr 1.6mg/dL, baseline = 1.3mg/dL), hypokalemia (K 3mmol/L), elevated AST (51), elevated CRP (8.88), positive d-dimer (1.02), normal lactate, and negative troponin. CTA chest was negative for PE, but did reveal significant opacities in peripheral RUL and RMLs. While in the ED, HR was noted to decline to the 30s. EKG was obtained and revealed bifasicular block. Previous EKG was also noted to have to have bifasicular block (8/25/2020). Patient was given LR x 1L, magnesium sulfate 2g IV x 1, potassium chloride 40mEq PO x 1, albuterol/ipratropium neb x 1, and dexamethasone 10mb IVP x 1 in the ED. He was admitted to ICU for further care. Updated of Present Illness: 2/14/2022 - Dexamethasone was continued on admission. Remdesivir, azithromycin, and ceftriaxone initiated. ID consulted. HFNC was placed. Overnight, Patient was noted to have intermittent second degree heart block. Cardiology consulted. FiO2 requirements increased overnight. 2/15/2022 - Blood cultures are growing Streptococcus species in 1/4 bottles. HFNC continues. FiO2 requirements have decreased over the past 24 hours. 2/16/2022 - Blood cultures grew Streptococcus gordonii with intermediate susceptibility to penicillin and ceftriaxone. Vancomycin initiated. Patient was weaned to 6LPM this morning. 2/17/2022 - Patient remains on 6LPM via nasal cannula this AM. Repeat blood cultures pending. Patient converted to 2nd degree AV block type II this AM. This asymptomatic. 2/18/2022 - 2nd degree AV block has resolved. Patient was placed on 10LPM via oxymizer yesterday and has been tapered to 7LPM this AM. He reports feeling better. 2/22/2022 - Repeat blood cultures negative on final report. Oxygen requirements have decreased to 6LPM via oxymizer. Dexmeathsone concluded this AM. Patient reports feel much better.
Generalized Aching; chills; Feverish; Headache; This spontaneous case was reported by a physician and describes the occurrence of PAIN (Generalized Aching), CHILLS (chills), PYREXIA (Feverish) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ADALIMUMAB (HUMIRA) for Panuveitis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Generalized Aching), CHILLS (chills), PYREXIA (Feverish) and HEADACHE (Headache). At the time of the report, PAIN (Generalized Aching), CHILLS (chills), PYREXIA (Feverish) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was not reported. No treatment medication was not reported
period lasting long from first shot; This spontaneous case was reported by a consumer and describes the occurrence of OLIGOMENORRHOEA (period lasting long from first shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OLIGOMENORRHOEA (period lasting long from first shot). At the time of the report, OLIGOMENORRHOEA (period lasting long from first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.   Reporter did not allow further contact
9/29/2017 pt. began experiencing terrible pain and burning in her eyes with tearing, burning inside her ears and itching about her body. 10/1/17 symptoms got worse. 10/2/17 pt. went to hospital. 10/20/17 pt. saw ophthalmologist.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/8/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting), ILLNESS (still sick), CHILLS (Chills) and MYALGIA (Muscle aches and pain) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting) and CHILLS (Chills). On an unknown date, the patient experienced ILLNESS (still sick), MYALGIA (Muscle aches and pain) and PYREXIA (fever of 104.1/High fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 26-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting) and MYALGIA (Muscle aches and pain) outcome was unknown and ILLNESS (still sick) and PYREXIA (fever of 104.1/High fever) had not resolved.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.1 (High) body temperature -104.1 (High fever). For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up information received on 08-JUN-2021contains significant information- new event-sick added, lab data fever 104.1 added, contact information updated. On 21-Jul-2021: Follow up received contains: Updated patient information- Height, Weight, Race, Ethnicity; Updated event- Muscle aches and pain; Updated event outcomes- events are ongoing and recurring.